利民股份：阿维菌素等产品在四季度处于淡季，需求下降导致价格下跌，后续价格预计会周期性反弹

Group 1 - The core viewpoint of the article is that the price changes of the company's products are primarily influenced by supply and demand dynamics, with significant price increases for key products like Mancozeb and Chlorothalonil, while prices for products like Abamectin are expected to rebound after a seasonal decline [2][3] - The company indicated that the strong demand for its fungicides, such as Mancozeb and Chlorothalonil, is expected to lead to sustained price increases through 2025 [2] - The impact on the company's performance is influenced not only by price changes but also by factors such as volume and costs, with Mancozeb and Chlorothalonil expected to have a greater overall impact on performance compared to Abamectin [2]